So we know that something is going on here. The next steps are to control potential confounding variables and to determine the sensitivity and specificity of the test, if it's shown that she's not actually detecting some confounding variable. This is where you go double-blind, you use larger sample sizes, et cetera, now that you have money. You have money because the preliminary research was promising.
And we're not just getting a good test out of this. If there's an actual chemical that she's smelling, then there's some chemical process that's going on in people with Parkinson's which isn't happening in people without Parkinson's (or vice versa). Tracing these chemical pathways could give us clues to the etiology of the disease, which would be a REALLY BIG DEAL. Or maybe it's just a rabbit hole.